{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:20Z","timestamp":1781530340290,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1177\/1933719114549856","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T04:56:26Z","timestamp":1410929786000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Anti-M\u00fcllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review"],"prefix":"10.1007","volume":"22","author":[{"given":"Akira","family":"Iwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"issue":"6","key":"22050519_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685\u2013718.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"22050519_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0015-0282(03)00078-5","volume":"79","author":"LF Bancsi","year":"2003","unstructured":"Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril. 2003;79(5): 1091\u20131100.","journal-title":"Fertil Steril"},{"issue":"4","key":"22050519_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.fertnstert.2012.11.051","volume":"99","author":"SM Nelson","year":"2013","unstructured":"Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99(4):963\u2013969.","journal-title":"Fertil Steril"},{"issue":"11","key":"22050519_CR4","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1093\/humrep\/der271","volume":"26","author":"JS Loh","year":"2011","unstructured":"Loh JS, Maheshwari A. Anti-Mullerian hormone\u2014is it a crystal ball for predicting ovarian ageing? Hum Reprod. 2011;26(11): 2925\u20132932.","journal-title":"Hum Reprod"},{"issue":"3","key":"22050519_CR5","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","volume":"143","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143(3):1076\u20131084.","journal-title":"Endocrinology"},{"issue":"2","key":"22050519_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JS, Von Bergh AR, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77\u201383.","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"22050519_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.maturitas.2011.11.008","volume":"71","author":"RA Anderson","year":"2012","unstructured":"Anderson RA, Nelson SM, Wallace WH. Measuring anti-Mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas. 2012;71(1):28\u201333.","journal-title":"Maturitas"},{"issue":"2","key":"22050519_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","volume":"77","author":"A de Vet","year":"2002","unstructured":"de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357\u2013362.","journal-title":"Fertil Steril"},{"issue":"2","key":"22050519_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/humrep\/deg042","volume":"18","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18(2):323\u2013327.","journal-title":"Hum Reprod"},{"issue":"4","key":"22050519_CR10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","volume":"83","author":"IA van Rooij","year":"2005","unstructured":"van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83(4):979\u2013987.","journal-title":"Fertil Steril"},{"issue":"2","key":"22050519_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u2013130.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"22050519_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/humrep\/dep366","volume":"25","author":"J van Disseldorp","year":"2010","unstructured":"van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010;25(1):221\u2013227.","journal-title":"Hum Reprod"},{"issue":"15","key":"22050519_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u20132012.","journal-title":"JAMA"},{"issue":"18","key":"22050519_CR14","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","volume":"24","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917\u20132931.","journal-title":"J Clin Oncol"},{"issue":"6","key":"22050519_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ajog.2012.08.013","volume":"207","author":"JF McLaren","year":"2012","unstructured":"McLaren JF, Bates GW. Fertility preservation in women of reproductive age with cancer. Am J Obstet Gynecol. 2012;207(6): 455\u2013462.","journal-title":"Am J Obstet Gynecol"},{"issue":"31","key":"22050519_CR16","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1200\/JCO.2010.30.5748","volume":"28","author":"S Lee","year":"2010","unstructured":"Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol. 2010;28(31):4683\u20134686.","journal-title":"J Clin Oncol"},{"issue":"12","key":"22050519_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/sj.bjc.6603814","volume":"96","author":"K Lutchman Singh","year":"2007","unstructured":"Lutchman Singh K, Muttukrishna S, Stein RC, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer. 2007;96(12):1808\u20131816.","journal-title":"Br J Cancer"},{"issue":"2","key":"22050519_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","volume":"94","author":"AH Partridge","year":"2010","unstructured":"Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010;94(2):638\u2013644.","journal-title":"Fertil Steril"},{"issue":"3","key":"22050519_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.24746","volume":"116","author":"HI Su","year":"2010","unstructured":"Su HI, Sammel MD, Green J, et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer. 2010;116(3): 592\u2013599.","journal-title":"Cancer"},{"issue":"5","key":"22050519_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1210\/jc.2010-2582","volume":"96","author":"RA Anderson","year":"2011","unstructured":"Anderson RA, Cameron DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96(5):1336\u20131343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"22050519_CR21","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/humrep\/del201","volume":"21","author":"RA Anderson","year":"2006","unstructured":"Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006;21(10): 2583\u20132592.","journal-title":"Hum Reprod"},{"issue":"3","key":"22050519_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/07357900701829777","volume":"26","author":"C Anders","year":"2008","unstructured":"Anders C, Marcom PK, Peterson B, et al. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest. 2008;26(3):286\u2013295.","journal-title":"Cancer Invest"},{"issue":"2","key":"22050519_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10549-012-2361-5","volume":"137","author":"HI Su","year":"2013","unstructured":"Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ. Impact of breast cancer on anti-Mullerian hormone levels in young women. Breast Cancer Res Treat. 2013;137(2):571\u2013577.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"22050519_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10815-011-9567-z","volume":"28","author":"S Lee","year":"2011","unstructured":"Lee S, Ozkavukcu S, Heytens E, Moy F, Alappat RM, Oktay K. Anti-Mullerian hormone and antral follicle count as predictors for embryo\/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone. J Assist Reprod Genet. 2011;28(7):651\u2013656.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"22050519_CR25","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/humrep\/den248","volume":"23","author":"M Rosendahl","year":"2008","unstructured":"Rosendahl M, Andersen CY, Ernst E, et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod. 2008;23(11):2475\u20132483.","journal-title":"Hum Reprod"},{"issue":"2","key":"22050519_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10245330600954072","volume":"12","author":"L Giuseppe","year":"2007","unstructured":"Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007;12(2): 141\u2013147.","journal-title":"Hematology"},{"issue":"10","key":"22050519_CR27","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2006-2374","volume":"92","author":"RD van Beek","year":"2007","unstructured":"van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin\u2019s lymphoma during childhood. J Clin Endocrinol Metab. 2007;92(10):3869\u20133874.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"22050519_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","volume":"20","author":"C Decanter","year":"2010","unstructured":"Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010;20(2):280\u2013285.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"22050519_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/humrep\/dem392","volume":"23","author":"S Lie Fong","year":"2008","unstructured":"Lie Fong S, Lugtenburg PJ, Schipper I, et al. Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008;23(3):674\u2013678.","journal-title":"Hum Reprod"},{"issue":"1","key":"22050519_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","volume":"98","author":"B Lawrenz","year":"2012","unstructured":"Lawrenz B, Fehm T, von Wolff M, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2014evaluation by using antimullerian hormone and retrieved oocytes. Fertil Steril. 2012;98(1):141\u2013144.","journal-title":"Fertil Steril"},{"issue":"11","key":"22050519_CR31","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/humrep\/deg473","volume":"18","author":"LE Bath","year":"2003","unstructured":"Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003; 18(11):2368\u20132374.","journal-title":"Hum Reprod"},{"issue":"4","key":"22050519_CR32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/humrep\/den487","volume":"24","author":"S Lie Fong","year":"2009","unstructured":"Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod. 2009;24(4):982\u2013990.","journal-title":"Hum Reprod"},{"issue":"6","key":"22050519_CR33","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/annonc\/mdr511","volume":"23","author":"M van Waas","year":"2012","unstructured":"van Waas M, Neggers SJ, Te Winkel ML, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM. Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma. Ann Oncol. 2012;23(6):1626\u20131632.","journal-title":"Ann Oncol"},{"issue":"2","key":"22050519_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/pbc.23363","volume":"59","author":"H Hamre","year":"2012","unstructured":"Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fossa SD. Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study. Pediatr Blood Cancer. 2012;59(2):271\u2013277.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"22050519_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/pbc.24327","volume":"60","author":"H Morse","year":"2013","unstructured":"Morse H, Elfving M, Lindgren A, Wolner-Hanssen P, Andersen CY, Ora I. Acute onset of ovarian dysfunction in young females after start of cancer treatment. Pediatr Blood Cancer. 2013; 60(4):676\u2013681.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"22050519_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","volume":"99","author":"KE Dillon","year":"2013","unstructured":"Dillon KE, Sammel MD, Prewitt M, et al. Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013;99(2):477\u2013483.","journal-title":"Fertil Steril"},{"issue":"1","key":"22050519_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.fertnstert.2011.10.040","volume":"97","author":"CR Gracia","year":"2012","unstructured":"Gracia CR, Sammel MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(1): 134\u2013140 e131.","journal-title":"Fertil Steril"},{"issue":"6","key":"22050519_CR38","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jpeds.2010.11.019","volume":"158","author":"A Cuny","year":"2011","unstructured":"Cuny A, Trivin C, Brailly-Tabard S, et al. Inhibin B and anti-Mullerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr. 2011;158(6):1016\u20131022. e1011.","journal-title":"J Pediatr"},{"issue":"4","key":"22050519_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/09513590.2012.743008","volume":"29","author":"A Iwase","year":"2013","unstructured":"Iwase A, Sugita A, Hirokawa W, et al. Anti-Mullerian hormone as a marker of ovarian reserve in patients with ovarian malignancies who have undergone fertility-preserving surgery and chemotherapy. Gynecol Endocrinol. 2013;29(4):357\u2013360.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"22050519_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2012.11.021","volume":"167","author":"A Iwase","year":"2013","unstructured":"Iwase A, Sugita A, Hirokawa W, et al. Anti-Mullerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia. Eur J Obstet Gynecol Reprod Biol. 2013;167(2):194\u2013198.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"22050519_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/art.37719","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok CC, Chan PT, To CH. Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus. Arthritis Rheum. 2013; 65(1):206\u2013210.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"22050519_CR42","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1210\/jc.2013-1235","volume":"98","author":"N Morel","year":"2013","unstructured":"Morel N, Bachelot A, Chakhtoura Z, et al. Study of anti-Mullerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin Endocrinol Metab. 2013; 98(9):3785\u20133792.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"22050519_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631\u2013637.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"22050519_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.mehy.2011.12.015","volume":"78","author":"JG Franco Jr","year":"2012","unstructured":"Franco JG Jr, Oliveira JB, Petersen CG, Mauri AL, Baruffi R, Cavagna M. Adjuvant therapy with GnRH agonists\/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility. Med Hypotheses. 2012;78(4):442\u2013445.","journal-title":"Med Hypotheses"},{"issue":"7","key":"22050519_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/gme.0b013e318204af88","volume":"18","author":"AS Dieudonne","year":"2011","unstructured":"Dieudonne AS, Vandenberghe J, Geerts I, et al. Undetectable antimullerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor. Menopause. 2011;18(7):821\u2013824.","journal-title":"Menopause"},{"issue":"10","key":"22050519_CR46","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1447-0756.2012.01861.x","volume":"38","author":"A Jantke","year":"2012","unstructured":"Jantke A, Rendtorff R, Dittrich R, et al. Association between self-reported questionnaire data on fertility and results of hormone analyses in women after childhood cancer: a cross-sectional study. J Obstet Gynaecol Res. 2012;38(10):1254\u20131259.","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"22050519_CR47","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1210\/jc.2011-3180","volume":"97","author":"MF Brougham","year":"2012","unstructured":"Brougham MF, Crofton PM, Johnson EJ, Evans N, Anderson RA, Wallace WH. Anti-Mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. J Clin Endocrinol Metab. 2012; 97(6):2059\u20132067.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"22050519_CR48","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/acr.22013","volume":"65","author":"J Brouwer","year":"2013","unstructured":"Brouwer J, Laven JS, Hazes JM, Schipper I, Dolhain RJ. Levels of serum anti-Mullerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65(9):1534\u20131538.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"22050519_CR49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/GCO.0b013e32833b4f5c","volume":"22","author":"TS Domingues","year":"2010","unstructured":"Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol. 2010; 22(4):271\u2013276.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"22050519_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.maturitas.2009.06.007","volume":"63","author":"CB Lambalk","year":"2009","unstructured":"Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas. 2009;63(4):280\u2013291.","journal-title":"Maturitas"},{"issue":"12","key":"22050519_CR51","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10815-012-9880-1","volume":"29","author":"HW Li","year":"2012","unstructured":"Li HW, Ng EH, Wong BP, Anderson RA, Ho PC, Yeung WS. Correlation between three assay systems for anti-Mullerian hormone (AMH) determination. J Assist Reprod Genet. 2012; 29(12): 1443\u20131446.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"22050519_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1210\/jc.2013-3476","volume":"99","author":"O Rustamov","year":"2014","unstructured":"Rustamov O, Smith A, Roberts SA, et al. The measurement of anti-Mullerian hormone: a critical appraisal. J Clin Endocrinol Metab. 2014;99(3):723\u2013732.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"22050519_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.fertnstert.2014.05.014","volume":"102","author":"C Decanter","year":"2014","unstructured":"Decanter C, Peigne M, Mailliez A, et al. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive anti-Mullerian hormone assay. Fertil Steril. 2014;102(2):483\u2013487.","journal-title":"Fertil Steril"},{"issue":"6","key":"22050519_CR54","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.fertnstert.2014.02.046","volume":"101","author":"HI Su","year":"2014","unstructured":"Su HI, Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk FZ. Comparability of antimullerian hormone levels among commercially available immunoassays. Fertil Steril. 2014;101(6): 1766\u20131772.e1761.","journal-title":"Fertil Steril"},{"issue":"5","key":"22050519_CR55","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/humrep\/deu036","volume":"29","author":"P Welsh","year":"2014","unstructured":"Welsh P, Smith K, Nelson SM. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Hum Reprod. 2014;29(5):1035\u20131041.","journal-title":"Hum Reprod"},{"issue":"6","key":"22050519_CR56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1055\/s-0029-1241057","volume":"27","author":"J Donnez","year":"2009","unstructured":"Donnez J, Squifflet J, Dolmans MM. Frozen-thawed ovarian tissue retransplants. Semin Reprod Med. 2009;27(6):472\u2013478.","journal-title":"Semin Reprod Med"},{"issue":"6","key":"22050519_CR57","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.fertnstert.2009.12.065","volume":"94","author":"GD Smith","year":"2010","unstructured":"Smith GD, Serafini PC, Fioravanti J, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94(6):2088\u20132095.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114549856.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719114549856","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719114549856\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719114549856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114549856.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:33:46Z","timestamp":1656812026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719114549856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["22050519"],"URL":"https:\/\/doi.org\/10.1177\/1933719114549856","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"30 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}